Reply to this statement:

Regarding the recurrence of depression each one is different. Imipramine had a recurrence of 11 out of 38 or roughly 29%, Lithium with 23 out of 37 or roughly 62%, and the placebo with 23 out of 34 or roughly 68% recurrence. In this lab, the percentages and ratios are those that have taken the treatment but came with a recurrence. The treatment with the least recurrence of depression given the data from the table is Imipramine which also means that this would be the best treatment for those with depression. Out of the total the treatments together would have roughly over halfor 52% of having a recurrence. With the percentages given, this would also mean that imipramine would have the highest non recurrence out of the treatments. It's percentage would be about 71% while the others are around 45% or below a 50% chance of no recurrence.